Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19

Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal epithelial cells. Since there are currently no coded therapies or guidelines for treatment of COVID-19, this study aimed t...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Gabriella d'Ettorre, Giancarlo Ceccarelli, Massimiliano Marazzato, Giuseppe Campagna, Claudia Pinacchio, Francesco Alessandri, Franco Ruberto, Giacomo Rossi, Luigi Celani, Carolina Scagnolari, Cristina Mastropietro, Vito Trinchieri, Gregorio Egidio Recchia, Vera Mauro, Guido Antonelli, Francesco Pugliese, Claudio Maria Mastroianni
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2020-07-01
Rangatū:	Frontiers in Medicine
Ngā marau:	COVID-19 SARS-CoV-2 bacteriotherapy probiotic lactobacillus gut-lung axis
Urunga tuihono:	https://www.frontiersin.org/article/10.3389/fmed.2020.00389/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!